Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px

Document › Details

Valneva S.E.. (11/9/23). "Press Release: Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates". Saint Herblain.

	Organisation	Valneva S.E. (Nasdaq: VALN, Euronext Paris: VLA)
	Group	Valneva (Group)
	Organisation 2	Deerfield Management Company L.P.
	Group	Deerfield (Group)
	Product	Ixiaro®
	Product 2	VLA1553 chikungunya vaccine (Valneva)
	Person	Bühler, Peter (Valneva 202107– CFO ANNOUNCED before Quotient + Zaluvida + Stallergenes Greer + Lilly + Merck Serono)
	Person 2	Bachelot-Fontaine, Laetitia (Valneva 201404 Investor Relations + Communications Manager)

Original document
accessed by [iito] on 2023-11-12

Record changed: 2024-01-20

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for Valneva (Group)

[1] Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain....
[2] Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
[3] Valneva S.E.. (11/10/23). "Press Release: Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
[4] Valneva S.E.. (9/25/23). "Press Release: Valneva Announces New Ixiaro Supply Contract with the U.S. Government Worth a Minimum of $32 Million". Saint Herblain....
[5] Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain....
[6] Valneva S.E.. (10/4/22). "Press Release: Valneva Announces Closing of Upsized €102.9 Million Global Offering". Saint-Herblain....
[7] Valneva S.E.. (8/18/22). "Press Release: Valneva Provides Update on Ixiaro Supply Contract with U.S. Department of Defense". Saint-Herblain....
[8] Valneva S.E.. (8/8/22). "Press Release: Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15". New York, NY & Saint-Herblain....
[9] Valneva S.E.. (6/23/22). "Press Release: Valneva and Pfizer Announce Closing of Equity Investment". Saint-Herblain & New York, NY....
[10] Valneva S.E.. (6/20/22). "Press Release: Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15". Saint-Herblain & New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]